Comparison of real-time PCR instruments for the detection of melanoma cell markers [Poster]

Autor: Pichler, Martin, Tockner, S., Bauernhofer, Th., Samonigg, H., Dandachi, N.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3341::bd49f501f239790f9c8f91d2efb90595
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/105826

2261P A head-to-head comparison for detecting PIK3CA mutations in circulating tumor DNA of advanced HR+/HER2- breast cancer patients

Autor: Dandachi, N., Graf, R., Pancheri, L., Dobrić, N., Klocker, E.V., Suppan, C., Jost, P.J., Heitzer, E., Balic, M.

Publikováno v: In Annals of Oncology October 2023 34 Supplement 2:S1162-S1163

Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patients.

Autor: Suppan C; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Graf R; Institute of Human Genetics, Diagnostic and Research Center for Molecular Biomedicine (Austria), Medical University of Graz, Graz, Austria., Jahn S; Institute of Pathology, Medical University of Graz, Graz, Austria., Zhou Q; Institute of Human Genetics, Diagnostic and Research Center for Molecular Biomedicine (Austria), Medical University of Graz, Graz, Austria., Klocker EV; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Bartsch R; Department of Medicine 1, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria., Terbuch A; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Kashofer K; Institute of Pathology, Medical University of Graz, Graz, Austria., Regitnig P; Institute of Pathology, Medical University of Graz, Graz, Austria., Lindenmann J; Division of Thoracic Surgery and Hyperbaric Surgery, Department of Surgery, Medical University of Graz, Graz, Austria., Posch F; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Gerritsmann H; Novartis Pharma GmbH, Jakov-Lind-Straße 5, 1020, Vienna, Austria., Jost PJ; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.; Department of Medicine III, Klinikum rechts der Isar, TUM School of Medicine, Technical University of Munich, Munich, Germany., Heitzer E; Institute of Human Genetics, Diagnostic and Research Center for Molecular Biomedicine (Austria), Medical University of Graz, Graz, Austria.; BioTechMed-Graz, Graz, Austria.; Christian Doppler Laboratory for Liquid Biopsies for Early Detection of Cancer, Graz, Austria., Dandachi N; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria. nadia.dandachi@medunigraz.at.; Research Unit Epigenetic and Genetic Cancer Biomarkers, Medical University of Graz, Graz, Austria. nadia.dandachi@medunigraz.at., Balic M; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria. marija.balic@medunigraz.at.; Research Unit Translational Breast Cancer, Medical University of Graz, Graz, Austria. marija.balic@medunigraz.at.

Publikováno v: British journal of cancer [Br J Cancer] 2022 Feb; Vol. 126 (3), pp. 456-463. Date of Electronic Publication: 2021 Nov 09.

Deciphering the molecular landscape of metastatic lobular breast cancer.

Autor: Dandachi N; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria; Research Unit for Epigenetic and Genetic Cancer Biomarkers, Medical University of Graz, Graz, Austria., Balic M; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria; Unit for Translational Breast Cancer Research, Medical University of Graz, Graz, Austria. Electronic address: marija.balic@medunigraz.at.

Publikováno v: EBioMedicine [EBioMedicine] 2022 Dec; Vol. 86, pp. 104385. Date of Electronic Publication: 2022 Nov 28.

Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response.

Autor: Zhou Q; Institute of Human Genetics, Diagnostic & Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria.; Christian Doppler Laboratory for Liquid Biopsies for Early Detection of Cancer, Medical University of Graz, Graz, Austria., Gampenrieder SP; IIIrd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg, Austria.; Salzburg Cancer Research Institute with Laboratory of Immunological and Molecular Cancer Research (LIMCR) and Center for Clinical Cancer and Immunology Trials (CCCIT), Salzburg, Austria.; Cancer Cluster Salzburg, Salzburg, Austria., Frantal S; Department of Statistics, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria., Rinnerthaler G; IIIrd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg, Austria.; Salzburg Cancer Research Institute with Laboratory of Immunological and Molecular Cancer Research (LIMCR) and Center for Clinical Cancer and Immunology Trials (CCCIT), Salzburg, Austria.; Cancer Cluster Salzburg, Salzburg, Austria., Singer CF; Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Egle D; Department of Obstetrics and Gynecology, Medical University Innsbruck, Innsbruck, Austria., Pfeiler G; Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Bartsch R; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Wette V; Breast Center, Brustzentrum Kaernten, St. Veit, Austria., Pichler A; Department of Hemato-Oncology, LKH Hochsteiermark-Leoben, Leoben, Austria., Petru E; Department of Gynaecology and Obstetrics, Medical University Graz, Graz, Austria., Dubsky PC; Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Breast Center St. Anna, Lucerne, Switzerland., Bago-Horvath Z; Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Fesl C; Salzburg Cancer Research Institute with Laboratory of Immunological and Molecular Cancer Research (LIMCR) and Center for Clinical Cancer and Immunology Trials (CCCIT), Salzburg, Austria., Rudas M; Department of Pathology, Medical University of Vienna, Vienna, Austria., Ståhlberg A; Department of Laboratory Medicine, Sahlgrenska Center for Cancer Research, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenberg, Sweden.; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.; Region Västra Götaland, Sahlgrenska University Hospital, Department of Clinical Genetics and Genomics, Gothenburg, Sweden., Graf R; Institute of Human Genetics, Diagnostic & Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria., Weber S; Institute of Human Genetics, Diagnostic & Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria., Dandachi N; Division of Oncology, Department of Internal Medicine, Medical University Graz, Graz, Austria., Filipits M; Department of Medicine I, Comprehensive Cancer Center, Institute of Cancer Research, Medical University of Vienna, Vienna, Austria., Gnant M; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Balic M; Division of Oncology, Department of Internal Medicine, Medical University Graz, Graz, Austria., Heitzer E; Institute of Human Genetics, Diagnostic & Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria.; Christian Doppler Laboratory for Liquid Biopsies for Early Detection of Cancer, Medical University of Graz, Graz, Austria.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Feb 15; Vol. 28 (4), pp. 697-707.